C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 417/12 (2006.01) A61K 31/381 (2006.01) A61K 31/4164 (2006.01) A61K 31/44 (2006.01) A61K 31/549 (2006.01) A61P 25/00 (2006.01) A61P 25/28 (2006.01) C07C 311/08 (2006.01) C07D 213/40 (2006.01) C07D 277/28 (2006.01) C07D 333/20 (2006.01) C07D 409/12 (2006.01) C07D 417/14 (2006.01)
Patent
CA 2618474
The invention relates to substituted 1,2-ethylenediamines of general formula (I), wherein the radicals R1 - R13, A, B, L and i are as defined in the description and in the claims. The invention also relates to the use thereof for treating Alzheimer's disease (AD) and similar diseases.
La présente invention concerne des 1,2-éthylènediamines de formule générale (I) dans laquelle les radicaux R1 à R13, A, B, L et i sont tels que définis dans la description et les revendications, et l'utilisation desdites substances pour traiter la maladie d'Alzheimer (AD) et des pathologies similaires.
Dorner-Ciossek Cornelia
Eickmeier Christian
Fuchs Klaus
Handschuh Sandra
Heine Niklas
Boehringer Ingelheim International Gmbh
Fetherstonhaugh & Co.
LandOfFree
Compounds for treating alzheimer's disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds for treating alzheimer's disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds for treating alzheimer's disease will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1931746